Millipore Sigma Vibrant Logo

ABN1387 Anti-Beta-glucocerebrosidase (GBA)

Anti-Beta-glucocerebrosidase (GBA), Cat. No. ABN1387, is a highly specific mouse polyclonal antibody, that targets Glucosylceramidase and has been tested in ELISA, Immunohistochemistry (Paraffin), and Western Blotting.

Anti-Beta-glucocerebrosidase (GBA) MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Research Category: Neuroscience Gene Symbol: GBA, GC, GLUC UniProt Number: P04062
View Products on Sigmaaldrich.com
ABN1387
100 µL  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Special Offers

      100% Performance Guaranteed

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HELISA, IH(P), WBMSerumPolyclonal Antibody
      Description
      Catalogue NumberABN1387
      DescriptionAnti-Beta-glucocerebrosidase (GBA)
      Alternate Names
      • Glucosylceramidase
      • Acid beta-glucosidase
      • Alglucerase
      • Beta-GC
      • Beta-glucocerebrosidase
      • D-glucosyl-N-acylsphingosine glucohydrolase
      • Imiglucerase
      Background InformationGlucosylceramidase (EC 3.2.1.45; UniProt P04062; also known as Acid beta-glucosidase, Alglucerase, Beta-GC, Beta-glucocerebrosidase, D-glucosyl-N-acylsphingosine glucohydrolase, Imiglucerase) is encoded by the GBA (also known as GC, GLUC) gene (Gene ID 2629) in human. It is a 62 kDa membrane associated lysosomal enzyme that catalyzes the hydrolysis of glucocerebroside to glucose and ceramide. It requires a signal peptide for transport across the membrane of the rough endoplasmic reticulum and glycosylation for transport into lysosomes where it is activated by saposin C. Over 300 different mutations have been identified in the GBA gene that lead to the deficiency or complete absence of glucosylceramidase activity leading to Gaucher s disease, one of the most common inherited disorder involving accumulation of glycolipids in macrophages, mainly in liver, spleen, and bone marrow. This disease is characterized by enlargement of liver and spleen, liver malfunction, anemia, bone lesions, and severe neurologic complications. Ref.: Novo JB et al. (2010). Mol. Biotechnol. 46, 279-286.
      References
      Product Information
      FormatSerum
      PresentationMouse polyclonal antibody serum with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-Beta-glucocerebrosidase (GBA), Cat. No. ABN1387, is a highly specific mouse polyclonal antibody, that targets Glucosylceramidase and has been tested in ELISA, Immunohistochemistry (Paraffin), and Western Blotting.
      Key Applications
      • ELISA
      • Immunohistochemistry (Paraffin)
      • Western Blotting
      Application NotesImmunohistochemistry Analysis: A 1:250-1,000 dilution from a representative lot detected beta-glucocerebrosidase (GBA) in human cerebellum, cerebral cortex, and small intestine tissue sections.

      Western Blotting Analysis: A representative lot detected His-tagged recombinant full-length human mature beta-glucocerebrosidase (GBA) (Courtesy of Dr. Cláudia Sossai Soares and Paulo Lee Ho).

      ELISA Analysis: A representative lot detected purified recombinant human beta-glucocerebrosidase (GBA) (Novo, J.B., et al. (2010). Mol. Biotechnol. 46(3):279-286).

      Western Blotting Analysis: A representative lot detected bacterially expressed unglycosylated recombinant human beta-glucocerebrosidase (GBA), glycosylated human GBA expressed and secreted by COS-7 transfectants, as well as endogenous GBA in HeLa and ECV304 cell lysates (Novo, J.B., et al. (2010). Mol. Biotechnol. 46(3):279-286).
      Biological Information
      ImmunogenHis-tagged recombinant full-length human mature Beta-glucocerebrosidase (GBA).
      ConcentrationPlease refer to lot specific datasheet.
      HostMouse
      SpecificityThis mouse polyclonal antiserum detected the expected target band only in lysate from human beta-glucocerebrosidase-/GBA-transfected, but not untransfected, COS-7 cells. This polyclonal antiserum is reactive toward unglycosylated, glycosylated, as well as deglycosylated GBA following PNGase F treatment (Novo, J.B., et al. (2010). Mol. Biotechnol. 46(3):279-286).
      Species Reactivity
      • Human
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • GBA
      • GC
      • GLUC
      Purification MethodUnpurified.
      UniProt Number
      Molecular Weight~59 kDa observed. 59.72/55.60 kDa (pro-/mature isoform Long), 57.46/55.60 kDa (pro-/mature isoform Short), 29.90 kDa (isoform 3) calculated. Uncharacterized bands may be observed in some lysate(s).
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blotting in SK-N-SH cell lysate.

      Western Blotting Analysis: A 1,000 dilution of this antiserum detected beta-glucocerebrosidase (GBA) in 10 µg of SK-N-SH human neuroblastoma cell lysate.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt.
      Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
      Packaging Information
      Material Size100 µL
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      ABN1387 04054839114540